Pacific Green Achieves Planning Consent for its Limestone Coast, South Australia, 1.5GWh Battery Energy Parks 17-07-2024, 14:00

Deriv Expands Global Reach with 7 New Offices 4-05-2023, 20:40

Io Therapeutics, Inc., presented today results from studies of IRX4204, the company’s phase II clinical development stage, highly selective RXR nuclear receptor agonist compound, supporting its potential use for treatment of amyotrophic lateral sclerosis 16-07-2024, 20:26